A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
单位：[1]Department of Urology, Capital Medical University Beijing Chaoyang Hospital, Beijing 100020, China.北京朝阳医院[2]Institute of Organ Transplantation,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430032,China.科研平台器官移植研究所华中科技大学同济医学院附属同济医院器官移植[3]Kidney Transplantation Dialysis Center, The Second People's Hospital of Shanxi Province, Taiyuan, Shanxi 030012, China.[4]Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong 510120, China.广东省中医院[5]Department of Nephrology, Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang 310000, China.[6]Department of Urology, Ningbo Yinzhou Number. 2 Hospital, Ningbo, Zhejiang 315000, China.[7]Department of Organ Transplantation, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China.[8]Institute of Kidney Transplantation, The First Affiliated Hospital, Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.[9]Kidney Department, Southwest Hospital, The First Hospital Affiliated to The Third Military Medical University (Army Medical University), Chongqing 400000, China.[10]Organ Transplant Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, China.[11]Department of Urology, Kidney Transplantation Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200000, China.[12]Department of Urology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China.中山大学附属第三医院
第一作者单位：[1]Department of Urology, Capital Medical University Beijing Chaoyang Hospital, Beijing 100020, China.
通讯作者：
通讯机构：[1]Department of Urology, Capital Medical University Beijing Chaoyang Hospital, Beijing 100020, China.[*1]Department of Urology, Capital Medical University Beijing Chaoyang Hospital, Workers Stadium South Road, No. 8, Building B, 7th Floor, Beijing 100020, China
推荐引用方式(GB/T 7714)：
Zheng Xiang,Zhang Weijie,Zhou Hua,et al.A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients[J].CHINESE MEDICAL JOURNAL.2023,136(5):607-609.doi:10.1097/CM9.0000000000002604.
APA：
Zheng Xiang,Zhang Weijie,Zhou Hua,Cao Ronghua,Shou Zhangfei...&Wang Wei.(2023).A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients.CHINESE MEDICAL JOURNAL,136,(5)
MLA：
Zheng Xiang,et al."A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients".CHINESE MEDICAL JOURNAL 136..5(2023):607-609
